Hangzhou Biotest Biotech Co Ltd (688767) — Capital Reinvestment Ratio
Hangzhou Biotest Biotech Co Ltd (688767) has a Capital Reinvestment Ratio of 1.66x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥28.39 Million) in capital expenditures (CN¥47.02 Million). See Hangzhou Biotest Biotech Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hangzhou Biotest Biotech Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Hangzhou Biotest Biotech Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Hangzhou Biotest Biotech Co Ltd from 2017 to 2025. For live market cap and broader valuation context, see Hangzhou Biotest Biotech Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.22x | CN¥106.47 Million | CN¥129.87 Million | ▼ -35.9% |
| 2024 | 1.90x | CN¥128.83 Million | CN¥245.05 Million | ▲ +342.9% |
| 2023 | 0.43x | CN¥131.38 Million | CN¥56.42 Million | ▲ +68.8% |
| 2022 | 0.25x | CN¥703.21 Million | CN¥178.92 Million | ▲ +15.4% |
| 2021 | 0.22x | CN¥908.12 Million | CN¥200.20 Million | ▲ +70.5% |
| 2020 | 0.13x | CN¥446.07 Million | CN¥57.68 Million | ▼ -91.6% |
| 2019 | 1.54x | CN¥25.67 Million | CN¥39.47 Million | ▲ +157.0% |
| 2018 | 0.60x | CN¥21.17 Million | CN¥12.67 Million | ▼ -83.9% |
| 2017 | 3.73x | CN¥7.07 Million | CN¥26.37 Million | — |